Published Article

Retatrutide Cost: What It Actually Costs in 2026

AuthorDr. Aris Thorne
Published

Retatrutide Cost: What It Actually Costs in 2026

Retatrutide currently costs $150–$500/month from peptide vendors and $200–$600/month through compounding pharmacies — there's no FDA-approved version yet, so no insurance coverage and no official retail price.

Key Takeaways

  • No official price exists — retatrutide (LY3437943) is in Phase 3 clinical trials and has not been FDA-approved
  • Research peptide vendors charge roughly $40–$120 per 5mg vial, putting monthly costs at $150–$500 depending on dose
  • Compounded retatrutide from telehealth platforms runs $200–$600/month, often including physician oversight
  • When FDA-approved (projected 2027–2028), expect commercial pricing of $1,000–$1,500/month before insurance — similar to Zepbound/Mounjaro
  • Insurance does not cover it right now; it won't until there's an approved product on the market
  • Your biggest cost driver is dose — the difference between 2mg/week and 8mg/week can triple your monthly bill

What You're Actually Paying For

Before breaking down the numbers, here's the honest context: everything currently sold as "retatrutide" is either a raw research peptide or a compounded formulation made by a pharmacy. Eli Lilly, which is developing the drug, has not released it commercially.

That means the market is fragmented. You'll find wide price swings — sometimes $300/month, sometimes $900/month — for what is essentially the same molecule at the same dose. The difference comes down to vendor markup, formulation overhead, and how much clinical handholding is baked in.

For a deep look at where to source it, check out our guide on retatrutide where to buy.


Retatrutide Price: Research Peptide Market

The cheapest access point is the research peptide market. These are raw lyophilized vials sold by peptide suppliers. Pricing varies significantly by vial size and vendor reputation.

Vial SizePrice RangeWeeks of Supply at 2mg/wkWeeks of Supply at 6mg/wk
5mg vial$40–$120~2.5 weeks< 1 week
10mg vial$80–$200~5 weeks~1.7 weeks
15mg vial$120–$280~7.5 weeks~2.5 weeks
20mg vial$160–$350~10 weeks~3.3 weeks

Pro tip: Larger vials almost always cost less per mg. Buying a 20mg vial at $200 gives you a per-mg cost of $10, while a 5mg vial at $80 costs $16/mg. At higher doses, this adds up fast.

Higher-concentration vials (e.g., 10mg/mL instead of 5mg/mL) also reduce the volume of bacteriostatic water you need per injection, which matters at doses above 4mg/week.


Monthly Retatrutide Cost by Dose

Your actual monthly spend is almost entirely determined by your weekly dose. This is the most important calculation most budgeting guides skip over.

Weekly DoseMonthly mg NeededEst. Research Peptide CostEst. Compounded Cost
1mg/week~4.3mg$30–$70/month$150–$250/month
2mg/week~8.7mg$60–$140/month$175–$300/month
4mg/week~17.3mg$120–$280/month$250–$400/month
6mg/week~26mg$180–$420/month$350–$500/month
8mg/week~34.7mg$240–$560/month$400–$600/month
12mg/week~52mg$360–$840/month$500–$700/month

Most people start at 2mg/week and titrate up over 12–20 weeks. Check the retatrutide dosage guide for the full titration schedule.


Compounded Retatrutide Cost

Compounding pharmacies and telehealth platforms (like weight loss clinics that work with 503A compounders) offer a middle ground between raw peptides and a full pharmaceutical product.

Typical compounded retatrutide pricing in 2026:

  • Telehealth clinic packages: $250–$600/month, often bundling the peptide, physician consult, and sometimes lab work
  • Direct compounding pharmacy: $180–$450/month for the medication alone (requires a prescription)
  • Multi-month supply discounts: Some platforms offer 10–20% off when buying 3 months at a time

The main upside of going the compounded route is that you get a legitimate prescription and clinical oversight. The downside is cost — you're paying a significant premium over raw research peptides.


Retatrutide vs. Semaglutide vs. Tirzepatide: Price Comparison

If you're deciding between available GLP-1 options and retatrutide, here's a realistic cost comparison:

MedicationMechanismMarket StatusMonthly Cost (Research/Compound)Monthly Cost (Pharmacy/Retail)
RetatrutideTriple agonist (GLP-1 + GIP + Glucagon)Phase 3 trials — not approved$150–$600N/A (not available)
SemaglutideGLP-1 agonistFDA-approved (Wegovy/Ozempic)$100–$350 (compound)$900–$1,350 (retail)
TirzepatideDual agonist (GLP-1 + GIP)FDA-approved (Zepbound/Mounjaro)$150–$450 (compound)$900–$1,100 (retail)

On paper, retatrutide isn't dramatically more expensive than its approved counterparts when sourced through similar channels. The bigger difference is that semaglutide and tirzepatide have FDA-approved versions that may qualify for insurance coverage, while retatrutide does not — yet.

Curious about when retatrutide will be commercially available? See our when will retatrutide be available guide for the latest trial timeline.


Retatrutide Cost Without Insurance

Short answer: you're paying out of pocket, entirely, right now.

Because retatrutide has no FDA approval and no commercial product, no insurance plan covers it. That's true whether you're buying research peptides or using a compounding pharmacy. There is no billing code, no prior authorization pathway, and no manufacturer patient assistance program — Eli Lilly only offers those for approved products.

What this means practically:

  • No copay assistance — Lilly's savings cards don't apply to an unapproved molecule
  • No HSA/FSA gray area loophole that works reliably
  • No Medicare/Medicaid coverage at any tier

If you're currently on Wegovy or Zepbound with insurance coverage and wondering whether to switch, that financial picture changes dramatically — you'd be going from a subsidized prescription to full out-of-pocket expense on an unapproved compound.


What Drives Retatrutide Prices Up (or Down)

Several factors swing your actual cost significantly:

Vendor type and overhead: Peptide vendors with minimal overhead charge less. Telehealth platforms with physician teams, customer support, and lab-work integration charge more — and that overhead has real value if you want clinical guidance.

Vial concentration: Higher concentration (10mg/mL vs. 5mg/mL) doesn't always cost more per mg, but it affects how long your supply lasts at a given dose. Ask vendors about concentration, not just total mg.

Volume discounts: Many vendors reduce per-mg pricing when you order 2–4 vials at once. If you're planning to use retatrutide for 3+ months, buying in bulk typically saves 15–25%.

Purity and testing: Reputable vendors post third-party HPLC and mass spec results. Peptides with verified purity tend to cost more upfront — but you're actually getting what you paid for. Lower prices sometimes mean lower purity or mislabeled dosing.

Geographic location: US-based vendors generally cost more than overseas suppliers but carry lower import risk. Shipping internationally also adds cost and customs uncertainty.


Is There a Retatrutide Coupon?

Not in the traditional sense. There's no GoodRx discount, no Eli Lilly coupon, and no major coupon aggregator with a retatrutide listing — because those only apply to pharmacy-dispensed, FDA-approved drugs.

What does exist:

  • Vendor discount codes: Many peptide vendors run seasonal promotions or first-order discounts (5–15% off). Subscribing to their email list usually gets you these.
  • Referral programs: Some vendors offer credit when you refer others.
  • Bulk pricing: As noted above, ordering more at once is the closest thing to a real discount.
  • Loyalty tiers: A few vendors offer reduced pricing for repeat customers after a certain spend threshold.

If you're looking for a vendor with consistent pricing and quality testing, check out Ascension Peptides — they're one of the more transparent vendors in this space with published purity testing on their retatrutide stock.


Cost-Saving Tips for Retatrutide

1. Start low and titrate slowly. Beginning at 1–2mg/week and holding there for 4–8 weeks before increasing keeps your monthly mg consumption — and cost — much lower in the early months.

2. Buy larger vials. The per-mg price almost always drops as vial size increases. If you're going to use 30mg over 10 weeks, buying a 30mg vial (if available) beats buying six 5mg vials.

3. Use a higher concentration formulation. 10mg/mL vials last longer at the same dose than 5mg/mL. Fewer reconstitutions also means less potential for contamination.

4. Compare vendors by price-per-mg, not sticker price. A $120 vial at 10mg is $12/mg. A $60 vial at 5mg is also $12/mg. A $150 vial at 15mg is $10/mg. Always do the math.

5. Track your dose carefully. Many people overshoot doses due to inaccurate measurement. A quality insulin syringe with 0.5-unit markings pays for itself in reduced peptide waste.

6. Plan around trial access. If you qualify for the TRIUMPH Phase 3 trials (check ClinicalTrials.gov), participation provides free access to the actual Eli Lilly product under physician supervision — zero cost to you, with proper clinical monitoring.


What to Expect When Retatrutide Gets FDA Approval

Based on Mounjaro's launch price ($1,000/month) and Wegovy ($1,350/month), expect approved retatrutide to land somewhere between $1,000 and $1,500/month at list price.

What that actually means for your wallet depends heavily on insurance coverage. If Eli Lilly secures broad obesity drug coverage — which is still politically contested in the US — your out-of-pocket might drop to $25–$50/month through manufacturer savings programs, the same way Zepbound works today.

Until then, out-of-pocket via compounding or research sources remains the only route.


Frequently Asked Questions

How much does retatrutide cost per month?
It depends on your dose and source. Research peptide vendors charge roughly $60–$420/month depending on weekly dose. Compounded retatrutide through telehealth runs $200–$600/month. There is no FDA-approved version available at retail yet.
Is retatrutide covered by insurance in 2026?
No. Retatrutide has not received FDA approval and has no commercial product on the market. Insurance plans — including Medicare, Medicaid, and private insurers — do not cover it. All current costs are out of pocket.
How does retatrutide cost compare to Ozempic or Zepbound?
Through similar channels (compounding pharmacies or research vendors), retatrutide costs about the same as compounded semaglutide or tirzepatide — roughly $150–$600/month. The big difference is that Ozempic and Zepbound have FDA-approved versions that may be covered by insurance, potentially dropping your cost to $25–$50/month with manufacturer savings cards. Retatrutide has no such program.
What will retatrutide cost when it's FDA approved?
Analysts project a list price of $1,000–$1,500/month based on comparable GLP-1 drugs. With insurance or Eli Lilly's anticipated savings program, real out-of-pocket could be much lower — potentially $25–$100/month for eligible patients. FDA approval is not expected before 2027.
Are there retatrutide coupons available?
Not through traditional pharmacy coupon programs like GoodRx. Eli Lilly does not have a savings card for retatrutide because there's no approved product. Some peptide vendors offer first-order discounts, referral credits, or bulk pricing breaks — those are the closest equivalent right now.
Why do prices vary so much between vendors?
Several factors: synthesis complexity, purity testing costs, vendor overhead, and market positioning. Some vendors cut costs by skipping third-party testing. Others charge a premium for verified purity data, better customer service, or faster shipping. Wide price variation is normal in the research peptide market — always check that a vendor publishes HPLC/mass spec results before buying.
How can I reduce my retatrutide costs?
Start at a lower dose (2mg/week) and titrate slowly — this cuts monthly mg usage significantly. Buy larger vials for better per-mg pricing. Order 2–3 months of supply at once for bulk discounts. Compare vendors by price-per-mg rather than total vial cost.

Medical Disclaimer: This article is for informational purposes only. Retatrutide is an investigational drug that has not been approved by the FDA or any other regulatory agency. Nothing in this article constitutes medical advice, and it should not be used as a substitute for professional medical guidance. Always consult a licensed healthcare provider before starting any new treatment or medication.

Continue Reading

Related posts

View Home
Dr. Aris Thorne02

Where to Buy Retatrutide in 2026

The best place to buy retatrutide in 2026 — a practical guide covering vetted vendors, COA verification, price expectations, shipping, and red flags to avoid.